Sejahtera Lestari Farma is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Jawa Timur. The company was founded in 2003. Sejahtera Lestari Farma was founded by Dr. Hadi Santoso and Dr. Rina Wijaya, who envisioned creating a company that would contribute to the health and well-being of the community through natural and effective medicinal products. The company focuses on the development and production of herbal medicines and botanical supplements, leveraging Indonesia's rich biodiversity. The primary business line of Sejahtera Lestari Farma is the manufacturing of herbal medicines, while its secondary line includes the production of dietary supplements. The company operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Bandung. Sejahtera Lestari Farma's main product types include herbal capsules, liquid extracts, and topical ointments. Some of their well-known brands are "HerbaSehat" and "Naturalis". The company exports its products to several countries in Southeast Asia, including Malaysia, Singapore, and Thailand. In terms of global operations, Sejahtera Lestari Farma is exploring opportunities to expand its footprint in the Asia-Pacific region. The company has established partnerships with local distributors and participates in joint ventures to enhance its market reach. Sejahtera Lestari Farma is a member of the Indonesian Herbal Medicine Association and actively collaborates with research institutions to innovate and improve its product offerings. The company's mission is to promote health and wellness through sustainable and eco-friendly practices, aiming to become a leading player in the herbal medicine industry in Asia.
Headquarters
Dusun Talun
Pasuruan; East Java;
Postal Code: 67154
Contact Details: Purchase the PT Sejahtera Lestari Farma report to view the information.
Website: http://www.selesfarma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service